Affiliation:
1. Universidade Federal de Mato Grosso, Brasil
Abstract
ABSTRACT Objective: To analyze scientific evidence on changes in the myocardial injury marker troponin and clinical outcome in patients hospitalized with COVID-19. Method: A scoping review was adopted, in the Medical Literature Analysis and Retrieval System Online, Scientific Electronic Library Online and Virtual Health Library bases, from May to July 2022. Using as descriptors: Troponin; COVID-19; Cardiovascular System. Results: 23 studies revealed cardiac alterations in hospitalized patients with COVID-19 by examining the cardio specific biomarker troponin, in addition to relating it to high mortality rates. Studies have shown a great relationship between acute myocardial injury, evidenced by elevated troponin, and a worse outcome during hospitalization. Conclusion: Cardiovascular changes were mapped in patients hospitalized with COVID -19 who progressed to severe cases of the disease. This study can contribute to care planning through protocols aimed at clinical management, specific for patients with the disease, both in the acute phase and in the post- COVID -19 phase.
Reference30 articles.
1. Extrapulmonary manifestations of SARS-CoV-2 infection;Carrillo-Esper R;Cir Cir,2020
2. Epidemiological, clinical and therapeutic aspects of COVID-19;Pereira MD;J Health Biol Sci,2020
3. Cardiac biomarker abnormalities are closely related to prognosis in patients with COVID-19;Tuo H;Int Heart J,2021
4. The heart and COVID-19: what the cardiologist needs to know;Costa IBS da S;Review Article. Arch. Bras. Cardiol,2020
5. Use of cardiac biomarkers in the detection of acute myocardial infarction;Borges LP;Revista Eletrônica Acervo Saúde,2019